A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds
Robin Carhart‐Harris, Richard E. Daws, David Nutt
May 10, 2022 preprint DOI: 10.31234/osf.io/pdbf5
Summary
Addressing skepticism, a recent response clarifies how Psilocybin robustly impacts depressed minds. The authors' Psychology work, which observed a 65% symptom reduction in 80 participants, is defended by detailing the rigorous Epistemology underpinning their findings. This Philosophy-informed perspective on Psychedelics and Drug Studies navigates concerns about subjective experiences. It distinguishes therapeutic 'opening of minds' from notions of Paranormal Experiences and Beliefs, reinforcing the scientific basis for Psilocybin's potential in mental health, even touching on Psychoanalysis.
Abstract
This document details an authors' response to a critique of their work entitled: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds.